Publication:
The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease

dc.contributor.authorVlajinac, Hristina D. (7006581450)
dc.contributor.authorMarinković, Jelena M. (7004611210)
dc.contributor.authorMaksimović, Miloš Z. (13613612200)
dc.contributor.authorRadak, Djordje J. (7004442548)
dc.contributor.authorArsić, Radomir B. (55179155400)
dc.contributor.authorJorga, Jagoda B. (6602324495)
dc.date.accessioned2025-06-12T15:26:40Z
dc.date.available2025-06-12T15:26:40Z
dc.date.issued2019
dc.description.abstractBackground Cardiovascular disease remains the major cause of mortality in the Western World. aims We aimed to assess the prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease (PAD), and to determine the risk profile of patients with polyvascular disease. methods The study included 1045 consecutive patients presenting to our department with carotid disease or PAD. Demographic characteristics, anthropometric parameters, and data on cardiovascular risk factors were collected in all patients. On the basis of medical history, patients were classified into those who had only symptomatic carotid disease or symptomatic PAD and those who had symptomatic polyvascular disease. results Carotid disease alone was reported in 366 participants (35%), PAD alone, in 199 (19%), and polyvascular disease, in 480 (46%). Compared with carotid disease, PAD was more often a component of polyvascular disease (P = 0.002) and was combined with a higher number of other atherosclerotic diseases (P = 0.02). Compared with patients with symptomatic atherosclerotic disease in only 1 territory, patients with various types of polyvascular disease more often had hypertension (P from 0.03 to <0.001), dyslipidemia (P <0.001), high‑sensitivity C‑reactive protein levels of 3 mg/l or higher (P = 0.005), and more often were current smokers (P <0.001) or former smokers (P from 0.03 to 0.001). conclusions We showed a high prevalence of symptomatic polyvascular disease in patients with carotid disease or PAD. The risk profile was worse in patients with polyvascular disease than in those with a disease in a single vascular territory. Copyright by the Author(s), 2019
dc.identifier.urihttps://doi.org/10.33963/KP.14945
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074087969&doi=10.33963%2fKP.14945&partnerID=40&md5=4bb2cf427631f0f1ed1972af313ab59f
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/5755
dc.subjectCarotid disease,
dc.subjectPeripheral vascular disease,
dc.subjectPoly vascular disease
dc.titleThe prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease
dspace.entity.typePublication

Files